SEC 13F Intelligence

Zevenbergen Capital Investments LLC / BMRN

Zevenbergen Capital Investments LLC’s Biomarin Pharmaceutical Inc Position

Does Zevenbergen Capital Investments LLC own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 614.7K shares worth $52M in Q4 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$52M
Q4 2019
Shares
614.7K
% of Portfolio
+1.93%
Quarters Held
5
position exited

Position History BMRN

Reported value by quarter
Q4 ’18: $36MQ4 ’18Q1 ’19: $42MQ1 ’19Q2 ’19: $55MQ2 ’19Q3 ’19: $40MQ3 ’19Q4 ’19: $52MQ4 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2019614.7K$52M+1.93%
Q3 2019590.3K$40M+1.52%
Q2 2019638.2K$55M+1.79%
Q1 2019472.8K$42M+1.49%
Q4 2018425.6K$36M+1.58%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Zevenbergen Capital Investments LLC’s full portfolio or all institutional holders of BMRN.